Orthobiologics

Exactech announced the successful first procedure using InterSep calcium sulfate bone void filler....

Replicel was granted patents in China, Europe and Russia addressing the use of fibroblast cell technology to treat chronically damaged tendons. ...

Collagen Matrix received FDA 510(k) clearance to market OssiMend® Bioactive Moldable Bone Graft Matrix....

Retrospective review of 163 patients at one-year follow-up revealed clinical evidence of BONESUPPORT's CERAMENT® bone void filler remodeling into bone...

FzioMed reached a milestone of 1/3 patient enrollment in a clinical study of Oxiplex® gel for reduction of pain following...

Bioventus introduced OSTEOAMP® SELECT Fiber allograft bone graft substitute for spine, foot/ankle, orthopedic and trauma procedures....

Bone Biologics received regulatory approval in Australia for a multicenter pilot clinical trial to evaluate NELL-1/DBX® in the treatment of degenerative disc disease....

Seikagaku commenced Italy launch of HyLink® single-injection viscosupplement for knee osteoarthritis....

AlloSource enrolled the first patient in a study to evaluate the effectiveness of ProChondrix CR® fresh cryopreserved osteochondral allograft, when used on...

Atreon Orthopedics received FDA 510(k) clearance to market the Rotium Bioresorbable Wick for the treatment of rotator cuff injuries....